{"result": "(\"entity\"<|>PUNCION ASPIRATIVA CON AGUJA FINA<|>EVENT<|>Fine-needle aspiration biopsy (PAAF) is a procedure used to evaluate thyroid nodules for malignancy based on cytological analysis.)\n##\n(\"entity\"<|>CATEGORÍA BETHESDA I<|>EVENT<|>Bethesda Category I indicates a non-diagnostic result from a fine-needle aspiration biopsy, suggesting the need for repeat biopsy.)\n##\n(\"entity\"<|>CATEGORÍA BETHESDA III<|>EVENT<|>Bethesda Category III indicates a follicular lesion or atypia of undetermined significance, which may warrant surgical intervention.)\n##\n(\"entity\"<|>CATEGORÍA BETHESDA IV<|>EVENT<|>Bethesda Category IV indicates a suspicious lesion for follicular neoplasm, associated with a 50-75% risk of malignancy.)\n##\n(\"entity\"<|>NODULOS TIROIDEOS<|>EVENT<|>Thyroid nodules are abnormal growths in the thyroid gland that may require evaluation and management based on their characteristics.)\n##\n(\"relationship\"<|>THYROID NODULE<|>PUNCION ASPIRATIVA CON AGUJA FINA<|>Fine-needle aspiration biopsy is recommended for evaluating thyroid nodules based on their size and risk of malignancy<|>8)\n##\n(\"relationship\"<|>CATEGORÍA BETHESDA I<|>PUNCION ASPIRATIVA CON AGUJA FINA<|>Bethesda Category I results indicate that a repeat fine-needle aspiration biopsy is necessary<|>7)\n##\n(\"relationship\"<|>CATEGORÍA BETHESDA III<|>PUNCION ASPIRATIVA CON AGUJA FINA<|>Bethesda Category III results may justify surgical treatment following fine-needle aspiration biopsy<|>6)\n##\n(\"relationship\"<|>CATEGORÍA BETHESDA IV<|>PUNCION ASPIRATIVA CON AGUJA FINA<|>Bethesda Category IV results indicate a suspicious lesion that may require further surgical evaluation<|>6)\n##\n(\"relationship\"<|>NODULOS TIROIDEOS<|>CATEGORÍA BETHESDA I<|>Thyroid nodules categorized as Bethesda I require further evaluation through repeat fine-needle aspiration<|>7)\n##\n(\"relationship\"<|>NODULOS TIROIDEOS<|>CATEGORÍA BETHESDA III<|>Thyroid nodules categorized as Bethesda III may necessitate surgical intervention<|>6)\n##\n(\"relationship\"<|>NODULOS TIROIDEOS<|>CATEGORÍA BETHESDA IV<|>Thyroid nodules categorized as Bethesda IV are associated with a significant risk of malignancy<|>6)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ;55:544.8.\n     31  Sobre      los diagnósticos citológicos siguiendo la clasificación Bethesda para\n         nódulos       tiroideos, señale la afirmación correcta:\n                                                                                                                                                 32  Según      las guías en        vigor, la punción           aspirativa con aguja fina (PAAF) en                       nódulos\n         A.   La categoría Bethesda I (no diagnóstica) implica repetir la punción aspirativa con aguja                                               tiroideos está indicada (señale la respuesta falsa):\n              fina (PAAF), a ser posible con             guía ecográfica.\n         B.   El resultado Bethesda III (lesión folicular o atipia de significado indeterminado) justifica                                           A.  De rutina en nódulos de moderada sospecha, independientemente del tamaño.\n              el tratamiento quirúrgico en todos los casos.                                                                                          B.  Con propósitos evacuadores en quistes simples.\n         C.   La categoría Bethesda IV (lesión sospechosa de neoplasia folicular) comporta un riesgo                                                 C.  En nódulos que vayan a ser sometidos a terapia ablativa mínimamente invasiva.\n              del 50-75% para malignidad.                                                                                                            D.  En nódulos de alta sospecha con tamaño entre 0,5-1 cm si coexisten adenopatías\n         D.   A y C son correctas.                                                                                                                       sospechosas.\n\n\n\n168                                                                                                                                                                                                                                                                                            169\n---\n                                                                                                                                                                                                                                                         TIROIDES                           3\n\n\n\n     COMENTARIO                                                                                                                                       33  Indique cuál        de los siguientes           factores no se         ha implicado         en la patogenia del bocio\n     La primera opción a la pregunta es claramente falsa. En efecto, las guías de la ATA reco-                                                            difuso no tóxico:\n     miendan la evaluación              citológica de los nódulos             tiroideos, dependiendo de su                tamaño y                        A.   Deficiencia de yodo.\n     riesgo ecográfico de malignidad:                                                                                                                     B.   Ciertos haplotipos de HLA que incrementan el riesgo de autoinmunidad tiroidea.\n     •   En caso de sospecha elevada o intermedia de malignidad en la ecografía tiroidea se reco-                                                         C. Exposición a ciertos factores ambientales como la deficiencia de selenio.\n         mienda punción aspirativa con aguja fina (PAAF) de los nódulos mayores o iguales de 1 cm.                                                        D.   Estímulo por la TSH. .\n     •   En caso de sospecha baja, se recomienda realizar PAAF en los nódulos mayores de 1,5 cm.\n     •   Y en caso      de sospecha        muy baja, se recomienda realizar opcionalmente en nódulos ma-\n         yores de 2 cm.                                                                                                                                   COMENTARIO\n     •   Finalmente, en los nódulos claramente benignos (puramente quísticos) no está indicado                                                            La aparición de un bocio difuso no tóxico se considera un proceso adaptativo del tiroides a\n         realizar PAAF.                                                                                                                                   cualquier factor que dificulta la síntesis de hormonas                         tiroideas. El yodo,       por su relativa es-\n     Recomendaciones similares se efectúan en otras guías, como las de la American Associa-                                                               casez en la naturaleza, es el principal factor limitante en la síntesis de hormonas tiroideas,\n     tion of Clinical Endocrinologists (AACE), National Comprehensive Cancer Network (NCCN),                                                              y es ampliamente conocido que la deficiencia de yodo se asocia                                con la    presencia de bocio\n     y las Sociedades de Endocrinología británica y coreana.                                                                                              en la población (bocio endémico) (opción A falsa).\n     En cuanto a la indicación de la PAAF en nódulos entre 0,5 y 1 cm de diámetro, las guías de                                                           Sin embargo, la autoinmunidad no se ha implicado en la patogénesis del bocio no tóxico\n     la ATA lo recomiendan en casos de extensión extratiroidea y metástasis ganglionares o a                                                              (opción B correcta).\n     distancia, recomendación que también aparece en las guías de la AACE. Así pues, la opción                                                            Por otra parte, aunque la deficiencia de yodo es el factor fundamental que explica el aumento\n     D es correcta.                                                                                                                                       del   tamaño del       tiroides,   también es       cierto   que no     toda la    población desarrolla          bocio    en   las\n     Igualmente son correctas las opciones B y C. En efecto, la evacuación del contenido quís-                                                            zonas     deficientes     en yodo y que igualmente              se ha    descrito la     presencia de bocio          endémico\n     tico   de   un nódulo      tiroideo    es   una   opción terapéutica           firmemente        establecida      desde     hace                     en áreas suficientes en yodo, lo que sugiere\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>ORGANIZATION<|>The American Association of Clinical Endocrinologists (AACE) provides guidelines for the evaluation and management of thyroid nodules.)\n##\n(\"entity\"<|>NATIONAL COMPREHENSIVE CANCER NETWORK<|>ORGANIZATION<|>The National Comprehensive Cancer Network (NCCN) offers guidelines for cancer treatment, including recommendations for thyroid nodule evaluation.)\n##\n(\"entity\"<|>THYROID NODULE<|>EVENT<|>Thyroid nodules are growths in the thyroid gland that may require evaluation through fine-needle aspiration biopsy (PAAF) based on their size and risk of malignancy.)\n##\n(\"entity\"<|>BETHESDA CLASSIFICATION<|>EVENT<|>The Bethesda Classification is a system used to categorize thyroid nodule cytology results to guide clinical management.)\n##\n(\"entity\"<|>YODO<|>GEO<|>Yodo is a chemical element essential for the synthesis of thyroid hormones, and its deficiency is linked to the development of goiter.)\n##\n(\"entity\"<|>GOITER<|>EVENT<|>Goiter is an enlargement of the thyroid gland that can occur due to various factors, including iodine deficiency.)\n##\n(\"entity\"<|>HLA<|>GEO<|>HLA (Human Leukocyte Antigen) refers to a group of genes that play a crucial role in the immune system and may influence the risk of autoimmune thyroid disease.)\n##\n(\"entity\"<|>SELENIO<|>GEO<|>Selenium is a trace element that is important for thyroid function and may impact the risk of thyroid disorders.)\n##\n(\"relationship\"<|>AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS<|>THYROID NODULE<|>The AACE provides guidelines for the evaluation of thyroid nodules, influencing clinical practice<|>7)\n##\n(\"relationship\"<|>NATIONAL COMPREHENSIVE CANCER NETWORK<|>THYROID NODULE<|>The NCCN offers recommendations for the management of thyroid nodules, impacting treatment decisions<|>7)\n##\n(\"relationship\"<|>THYROID NODULE<|>BETHESDA CLASSIFICATION<|>The Bethesda Classification is used to categorize thyroid nodules based on cytology results<|>8)\n##\n(\"relationship\"<|>YODO<|>GOITER<|>Iodine deficiency is a primary cause of goiter development in populations<|>9)\n##\n(\"relationship\"<|>HLA<|>GOITER<|>Certain HLA haplotypes may increase the risk of autoimmune thyroid disease, which can lead to goiter<|>6)\n##\n(\"relationship\"<|>SELENIO<|>GOITER<|>Selenium deficiency may contribute to thyroid dysfunction and the development of goiter<|>5)\n<|COMPLETE|>"}]}